A Proposed Diagnostic and Treatment Algorithm for the Management of Lumbar Discogenic Pain [Response to Letter]. [PDF]
Lorio MP, Block JE.
europepmc +1 more source
Developing low-carbon salbutamol MDI: assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152a. [PDF]
Moreira S +9 more
europepmc +1 more source
Randomised, double-masked trial to compare the efficacy, safety and immunogenicity of the biosimilar aflibercept FYB203 with reference aflibercept in patients with neovascular age-related macular degeneration. [PDF]
Balser S +6 more
europepmc +1 more source
Pharmaceutical quality and cost-effectiveness of branded versus generic medicines across 22 drug types and 8 therapeutic categories: a citizen-funded comparative study from regulated retail outlets in Kerala, India. [PDF]
Philips CA +7 more
europepmc +1 more source
Efficacy and safety of National Centralized Drug Procurement-procured versus non-National Centralized Drug Procurement oxaliplatin in unresectable or metastatic pancreatic cancer: a retrospective cohort study. [PDF]
Ye Z, Yang L, Zhang Y, Wang X, Rao Y.
europepmc +1 more source
Morphological subphenotypes in acute pancreatitis-related ARDS: limitations, extensions, and research priorities. [PDF]
Pensier J, De Jong A, Jaber S.
europepmc +1 more source
Integration of Ustekinumab Biosimilars into Inflammatory Bowel Disease Care: Evidence, Implementation, and Patient-Centered Considerations. [PDF]
Piche SL +4 more
europepmc +1 more source
Comment on: Use of intracameral antibiotics prophylaxis in patients with posterior capsular rupture during cataract surgery: systematic review and meta-analysis. [PDF]
Lam S.
europepmc +1 more source
The FDA's adoption of Bayesian methodology: transforming clinical trial justification from biosimilars to broader drug development. [PDF]
Niazi SK.
europepmc +1 more source
Editorial: Enhancing the social skills and social competence for children and adolescents with autism spectrum disorder. [PDF]
Budisteanu M.
europepmc +1 more source

